Market expansion Mayoly is expanding with an international footprint and recently appointed a General Manager for Central and Eastern Europe, signaling a push into new regional markets. Sales opportunities exist in distribution partnerships, co-promotion, and localized product launches in Gastroenterology and Dermocosmetics.

Leadership strength A family-owned, independent French lab with a long heritage and a clear growth agenda toward Consumer Healthcare leadership. This positions Mayoly as a stable partner for long-term contracts, exclusive distribution, and joint development initiatives with regional distributors and wholesalers.

Therapeutic focus Core emphasis on Gastroenterology and Dermocosmetics with established brands such as Topicrem and Charlieu, offering cross-sell opportunities to healthcare professionals and retailers through dermatology and OTC portfolios, including potential private-label or co-branding arrangements.

Operational control Ownership of production capabilities enables end-to-end supply security and faster time-to-market. This can be leveraged to offer reliable manufacturing partnerships, faster regulatory once-off projects, and joint development programs for new GI and dermocosmetic formulations.

Digital readiness Adoption of modern tech stack (iCIMS, Power BI, Qlik, Talend, Fortinet, Microsoft Teams) indicates data-driven sales operations and efficient collaboration. Use may attract channel partners seeking integrated CRM, analytics, and secure communication for joint sales, marketing, and distributor enablement.